Corrigendum to “Galabiosylceramide is present in human cerebrospinal fluid” (Biochemical and Biophysical Research Communications (2021) 536 (73–79), (S0006291X20322294), (10.1016/j.bbrc.2020.12.051))

Hisako Akiyama; Mitsuko Ide; Toshiyuki Yamaji; Yasuaki Mizutani; Yoshiki Niimi; Tatsuro Mutoh; Hiroyuki Kamiguchi; Yoshio Hirabayashi

doi:10.1016/j.bbrc.2021.01.065

Corrigendum to “Galabiosylceramide is present in human cerebrospinal fluid” (Biochemical and Biophysical Research Communications (2021) 536 (73–79), (S0006291X20322294), (10.1016/j.bbrc.2020.12.051))

Hisako Akiyama, Mitsuko Ide, Toshiyuki Yamaji, Yasuaki Mizutani, Yoshiki Niimi, Tatsuro Mutoh, Hiroyuki Kamiguchi, Yoshio Hirabayashi

研究成果: ジャーナルへの寄稿 › コメント/討論 › 査読

抄録

In this article, there was a mistake on p. 77. In the 1st column, line 1: “0.14 ± 0.07 nM” should be corrected to: “0.43 ± 0.21 nM”. The authors would like to apologize for any inconvenience caused.

本文言語	英語
ページ（範囲）	96
ページ数	1
ジャーナル	Biochemical and Biophysical Research Communications
巻	543
DOI	https://doi.org/10.1016/j.bbrc.2021.01.065
出版ステータス	出版済み - 05-03-2021

All Science Journal Classification (ASJC) codes

生物理学
生化学
分子生物学
細胞生物学

文献へのアクセス

10.1016/j.bbrc.2021.01.065

他のファイルとリンク

フィンガープリント

「Corrigendum to “Galabiosylceramide is present in human cerebrospinal fluid” (Biochemical and Biophysical Research Communications (2021) 536 (73–79), (S0006291X20322294), (10.1016/j.bbrc.2020.12.051))」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル

Akiyama, H., Ide, M., Yamaji, T., Mizutani, Y., Niimi, Y., Mutoh, T., Kamiguchi, H., & Hirabayashi, Y. (2021). Corrigendum to “Galabiosylceramide is present in human cerebrospinal fluid” (Biochemical and Biophysical Research Communications (2021) 536 (73–79), (S0006291X20322294), (10.1016/j.bbrc.2020.12.051)). Biochemical and Biophysical Research Communications, 543, 96. https://doi.org/10.1016/j.bbrc.2021.01.065

@article{5a94fa1eab72497ab252f5832dd546a6,

title = "Corrigendum to “Galabiosylceramide is present in human cerebrospinal fluid” (Biochemical and Biophysical Research Communications (2021) 536 (73–79), (S0006291X20322294), (10.1016/j.bbrc.2020.12.051))",

abstract = "In this article, there was a mistake on p. 77. In the 1st column, line 1: “0.14 ± 0.07 nM” should be corrected to: “0.43 ± 0.21 nM”. The authors would like to apologize for any inconvenience caused.",

author = "Hisako Akiyama and Mitsuko Ide and Toshiyuki Yamaji and Yasuaki Mizutani and Yoshiki Niimi and Tatsuro Mutoh and Hiroyuki Kamiguchi and Yoshio Hirabayashi",

note = "Publisher Copyright: {\textcopyright} 2021 The Author(s)",

year = "2021",

month = mar,

day = "5",

doi = "10.1016/j.bbrc.2021.01.065",

language = "English",

volume = "543",

pages = "96",

journal = "Biochemical and Biophysical Research Communications",

issn = "0006-291X",

publisher = "Academic Press Inc.",

}

Akiyama, H, Ide, M, Yamaji, T, Mizutani, Y, Niimi, Y, Mutoh, T, Kamiguchi, H & Hirabayashi, Y 2021, 'Corrigendum to “Galabiosylceramide is present in human cerebrospinal fluid” (Biochemical and Biophysical Research Communications (2021) 536 (73–79), (S0006291X20322294), (10.1016/j.bbrc.2020.12.051))', Biochemical and Biophysical Research Communications, vol. 543, pp. 96. https://doi.org/10.1016/j.bbrc.2021.01.065

Corrigendum to “Galabiosylceramide is present in human cerebrospinal fluid” (Biochemical and Biophysical Research Communications (2021) 536 (73–79), (S0006291X20322294), (10.1016/j.bbrc.2020.12.051)). / Akiyama, Hisako; Ide, Mitsuko; Yamaji, Toshiyuki その他.

In: Biochemical and Biophysical Research Communications, Vol. 543, 05.03.2021, p. 96.

研究成果: ジャーナルへの寄稿 › コメント/討論 › 査読

TY - JOUR

T1 - Corrigendum to “Galabiosylceramide is present in human cerebrospinal fluid” (Biochemical and Biophysical Research Communications (2021) 536 (73–79), (S0006291X20322294), (10.1016/j.bbrc.2020.12.051))

AU - Akiyama, Hisako

AU - Ide, Mitsuko

AU - Yamaji, Toshiyuki

AU - Mizutani, Yasuaki

AU - Niimi, Yoshiki

AU - Mutoh, Tatsuro

AU - Kamiguchi, Hiroyuki

AU - Hirabayashi, Yoshio

PY - 2021/3/5

Y1 - 2021/3/5

N2 - In this article, there was a mistake on p. 77. In the 1st column, line 1: “0.14 ± 0.07 nM” should be corrected to: “0.43 ± 0.21 nM”. The authors would like to apologize for any inconvenience caused.

AB - In this article, there was a mistake on p. 77. In the 1st column, line 1: “0.14 ± 0.07 nM” should be corrected to: “0.43 ± 0.21 nM”. The authors would like to apologize for any inconvenience caused.

UR - http://www.scopus.com/inward/record.url?scp=85100078936&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85100078936&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2021.01.065

DO - 10.1016/j.bbrc.2021.01.065

M3 - Comment/debate

C2 - 33526262

AN - SCOPUS:85100078936

SN - 0006-291X

VL - 543

SP - 96

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

ER -

Akiyama H, Ide M, Yamaji T, Mizutani Y, Niimi Y, Mutoh T その他. Corrigendum to “Galabiosylceramide is present in human cerebrospinal fluid” (Biochemical and Biophysical Research Communications (2021) 536 (73–79), (S0006291X20322294), (10.1016/j.bbrc.2020.12.051)). Biochemical and Biophysical Research Communications. 2021 3月 5;543:96. doi: 10.1016/j.bbrc.2021.01.065